×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Moneycontrol mutual fund summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Teva
Teva
Ads
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits
Teva settles patent dispute with Aurobindo Pharma
Mylan surges, Teva slumps after FDA approves Copaxone copy
Analysts consensus is bearish on pharma stocks – should one buy?
Neuland refuses to comment on link between stock spike & Teva
Breakthrough drug for Huntington disease drives Neuland up 20%
Valeant's drug launch hits Lupin, but may signal Sun launch
US Court rules in favour of Mylan for Copaxone patents: Natco
US files first charges in generic drug price-fixing probe
Aurobindo arm to acquire select products in France from Teva
Sun Pharma falls 7%, sector under pressure on US probe fear
Teva assets complementary to Intas' business: CEO
Eye acqusitions in US, Europe; to list in 3-5 yrs: Intas Pharma
Intas buys Teva's European assets for $764 million
Aurobindo's topline can swell by $350 m with Teva buy: PL
See Nuvaring opportunity for Dr Reddy's in Q4FY18: Credit Suisse
Dr Reddy's completes acquisition of 8 ANDAs from Teva Pharma
No disturbing trend in Dr Reddy's numbers except topline: Expert
Cadila Healthcare gains 2% as arm acquires 2 ANDAs from US firm
Aurobindo Pharma gets USFDA nod for oral contraceptives
Cipla Q2 profit seen up 74% on export formulation biz boost
Cipla Q1 profit seen up 47% on higher other income, revenue
Weakness in Sun Pharma a buying opportunity: IIFL
Positive on Lupin on strong pipeline for US mkt: IIFL
Natco Pharma surges over 50% in 6 days, Antique says buy
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio